Logo image of ADUS

ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis

USA - NASDAQ:ADUS - US0067391062 - Common Stock

120.84 USD
-0.58 (-0.48%)
Last: 10/21/2025, 12:47:55 PM
Fundamental Rating

6

Taking everything into account, ADUS scores 6 out of 10 in our fundamental rating. ADUS was compared to 101 industry peers in the Health Care Providers & Services industry. While ADUS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ADUS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ADUS had positive earnings in the past year.
ADUS had a positive operating cash flow in the past year.
ADUS had positive earnings in each of the past 5 years.
In the past 5 years ADUS always reported a positive cash flow from operatings.
ADUS Yearly Net Income VS EBIT VS OCF VS FCFADUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

ADUS's Return On Assets of 5.89% is amongst the best of the industry. ADUS outperforms 81.19% of its industry peers.
With a decent Return On Equity value of 8.12%, ADUS is doing good in the industry, outperforming 67.33% of the companies in the same industry.
ADUS's Return On Invested Capital of 6.98% is fine compared to the rest of the industry. ADUS outperforms 69.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADUS is below the industry average of 9.33%.
Industry RankSector Rank
ROA 5.89%
ROE 8.12%
ROIC 6.98%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ADUS Yearly ROA, ROE, ROICADUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

ADUS has a better Profit Margin (6.51%) than 83.17% of its industry peers.
ADUS's Profit Margin has improved in the last couple of years.
ADUS has a Operating Margin of 9.13%. This is in the better half of the industry: ADUS outperforms 76.24% of its industry peers.
In the last couple of years the Operating Margin of ADUS has grown nicely.
With a Gross Margin value of 32.59%, ADUS perfoms like the industry average, outperforming 59.41% of the companies in the same industry.
ADUS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.13%
PM (TTM) 6.51%
GM 32.59%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
ADUS Yearly Profit, Operating, Gross MarginsADUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ADUS is destroying value.
ADUS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ADUS has been increased compared to 5 years ago.
ADUS has a worse debt/assets ratio than last year.
ADUS Yearly Shares OutstandingADUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADUS Yearly Total Debt VS Total AssetsADUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

ADUS has an Altman-Z score of 5.15. This indicates that ADUS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.15, ADUS belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
The Debt to FCF ratio of ADUS is 1.81, which is an excellent value as it means it would take ADUS, only 1.81 years of fcf income to pay off all of its debts.
ADUS has a better Debt to FCF ratio (1.81) than 85.15% of its industry peers.
ADUS has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ADUS has a better Debt to Equity ratio (0.17) than 71.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.81
Altman-Z 5.15
ROIC/WACC0.85
WACC8.25%
ADUS Yearly LT Debt VS Equity VS FCFADUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ADUS has a Current Ratio of 1.74. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
ADUS's Current ratio of 1.74 is fine compared to the rest of the industry. ADUS outperforms 63.37% of its industry peers.
A Quick Ratio of 1.74 indicates that ADUS should not have too much problems paying its short term obligations.
ADUS has a better Quick ratio (1.74) than 65.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
ADUS Yearly Current Assets VS Current LiabilitesADUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.13% over the past year.
Measured over the past years, ADUS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.61% on average per year.
ADUS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.29%.
ADUS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.22% yearly.
EPS 1Y (TTM)11.13%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%10.37%
Revenue 1Y (TTM)14.29%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%21.79%

3.2 Future

The Earnings Per Share is expected to grow by 10.72% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.83% on average over the next years. This is quite good.
EPS Next Y18.34%
EPS Next 2Y14.56%
EPS Next 3Y13.16%
EPS Next 5Y10.72%
Revenue Next Year22.44%
Revenue Next 2Y14.26%
Revenue Next 3Y11.16%
Revenue Next 5Y8.83%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADUS Yearly Revenue VS EstimatesADUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
ADUS Yearly EPS VS EstimatesADUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.62, ADUS is valued on the expensive side.
ADUS's Price/Earnings ratio is a bit cheaper when compared to the industry. ADUS is cheaper than 67.33% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.69. ADUS is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.57, ADUS is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ADUS is valued a bit cheaper than the industry average as 71.29% of the companies are valued more expensively.
ADUS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.18.
Industry RankSector Rank
PE 21.62
Fwd PE 17.57
ADUS Price Earnings VS Forward Price EarningsADUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ADUS is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, ADUS is valued a bit cheaper than 60.40% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.75
EV/EBITDA 17.69
ADUS Per share dataADUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ADUS may justify a higher PE ratio.
ADUS's earnings are expected to grow with 13.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.18
PEG (5Y)1.3
EPS Next 2Y14.56%
EPS Next 3Y13.16%

0

5. Dividend

5.1 Amount

ADUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (10/21/2025, 12:47:55 PM)

120.84

-0.58 (-0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners104.58%
Inst Owner Change-0.29%
Ins Owners2.4%
Ins Owner Change0.23%
Market Cap2.22B
Analysts84.44
Price Target144.75 (19.79%)
Short Float %3.47%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.93%
Min EPS beat(2)-0.58%
Max EPS beat(2)4.43%
EPS beat(4)2
Avg EPS beat(4)0.91%
Min EPS beat(4)-0.68%
Max EPS beat(4)4.43%
EPS beat(8)6
Avg EPS beat(8)4.5%
EPS beat(12)10
Avg EPS beat(12)5.23%
EPS beat(16)12
Avg EPS beat(16)4.17%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-1.14%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.3%
Revenue beat(12)0
Avg Revenue beat(12)-1.38%
Revenue beat(16)0
Avg Revenue beat(16)-1.87%
PT rev (1m)0%
PT rev (3m)4%
EPS NQ rev (1m)0.2%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0.3%
EPS NY rev (3m)-0.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.84%
Valuation
Industry RankSector Rank
PE 21.62
Fwd PE 17.57
P/S 1.75
P/FCF 23.75
P/OCF 22.15
P/B 2.18
P/tB N/A
EV/EBITDA 17.69
EPS(TTM)5.59
EY4.63%
EPS(NY)6.88
Fwd EY5.69%
FCF(TTM)5.09
FCFY4.21%
OCF(TTM)5.45
OCFY4.51%
SpS69.21
BVpS55.51
TBVpS-2.91
PEG (NY)1.18
PEG (5Y)1.3
Profitability
Industry RankSector Rank
ROA 5.89%
ROE 8.12%
ROCE 9.25%
ROIC 6.98%
ROICexc 7.52%
ROICexgc 96.54%
OM 9.13%
PM (TTM) 6.51%
GM 32.59%
FCFM 7.35%
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexcg growth 3Y20.44%
ROICexcg growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.81
Debt/EBITDA 1.29
Cap/Depr 46.6%
Cap/Sales 0.53%
Interest Coverage 12.85
Cash Conversion 76.79%
Profit Quality 112.88%
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 5.15
F-Score4
WACC8.25%
ROIC/WACC0.85
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)11.13%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%10.37%
EPS Next Y18.34%
EPS Next 2Y14.56%
EPS Next 3Y13.16%
EPS Next 5Y10.72%
Revenue 1Y (TTM)14.29%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%21.79%
Revenue Next Year22.44%
Revenue Next 2Y14.26%
Revenue Next 3Y11.16%
Revenue Next 5Y8.83%
EBIT growth 1Y15.88%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year45.09%
EBIT Next 3Y18.3%
EBIT Next 5Y14.43%
FCF growth 1Y-0.88%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y-2.52%
OCF growth 3Y43.4%
OCF growth 5Y57.54%